- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order fda.gov
- FDA fast-tracks psychedelic drug research following Trump executive order CNBC
- FDA plans ultra-fast review of three psychedelic drugs following Trump directive AP News
- Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic CNN
- Donald Trump is giving psychedelic medicines a welcome boost The Economist
News
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order – fda.gov
